273
July 23, 2021
IPO Alert: Glenmark Life Sciences Ltd.
Glenmark Life Sciences Limited (“GLS”) is a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. The company is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”). GLS partners with 16 of the top 20 generic companies in the world and serves customers in multiple countries.
| Bid/Offer Opens On | Tuesday, 27-Jul-21 |
| Bid/Offer Closes On | Thursday, 29-Jul-21 |
| Price Band | Rs. 695- Rs. 720 per equity share |
| Lot Size | 20 Shares |
EVERYTHING YOU NEED TO KNOW ABOUT GLENMARK IPO
| Finalization of Basis of Allotment | 3-Aug-21 |
| Initiation of Refunds | 4-Aug-21 |
| Credit of Shares to Demat Acct | 5-Aug-21 |
| IPO Shares Listing Date | 6-Aug-21 |
| UPI mandate expiry date | 12-Aug-21 |
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date as mentioned in the above table. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.
